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Abstract
Background: Dairy products consumption is increasingly common globally. Most of the evidence concerning dairy products
comes from observational studies in western populations which are inevitably open to confounding. To triangulate the
evidence concerning dairy products, we examined the associations of whole cow’s milk consumption with cardiovascular
risk factors in a non-Western setting with a different pattern of milk consumption and cardiovascular diseases from Western
populations.
Methods:We used multivariable censored linear or logistic regression to examine cross-sectionally the adjusted associations
of whole cow’s milk consumption (none (n = 14892), 1–3/week (n = 2689) and 3+/week (n = 2754)) with cardiovascular risk
factors in Chinese ($50 years) in the Guangzhou Biobank Cohort Study.
Results:Whole cow’s milk consumption was negatively associated with systolic blood pressure (3+/week compared to none
22.56 mmHg, 95% confidence interval (CI) 23.63 to 21.49), diastolic blood pressure (21.32 mmHg, 95% CI 21.87 to
20.77) and triglycerides (20.06 mmol/L, 95% CI 20.11 to 20.002), but was positively associated with HDL-cholesterol
(0.02 mmol/L,95% CI 0.01 to 0.04) and fasting glucose (0.08 mmol/L, 95% CI 0.01 to 0.16) adjusted for age, sex, phase of
study, socio-economic position, lifestyle (smoking, alcohol use and physical activity) and adiposity, but had no obvious
association with LDL-cholesterol or the presence of diabetes.
Conclusions: Whole cow’s milk consumption had heterogeneous associations with cardiovascular risk factors. Higher whole
cow’s milk consumption was associated with lower levels of specific cardiovascular risk factors which might suggest risk
factor specific biological pathways with different relations to blood pressure and lipids than glucose.
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Introduction
Cardiovascular disease (CVD) is the leading cause of death
worldwide[1]. According to the World Health Organization, by
2030, almost 24 million people will die from CVD, mainly from
heart disease and stroke[1]. Observational studies in western
settings suggest cow’s milk consumption influences CVD and its
risk factors[2], including diabetes[3]. Meta-analyses of prospective
cohort studies found a modest inverse association of total milk
intake with CVD in western settings, and possibly diabetes[3].
However, when studies were restricted to whole milk, prospective
cohort studies show no association or whole milk positively
associated with CVD and diabetes[3–6]._ENREF_5 _ENRE-
F_6_ENREF_9Inevitably with observational studies of a socially
and culturally patterned behavior it is uncertain whether these
associations are due to the biological properties of cow’s milk or to
other attributes of cow’s milk drinkers, because in western settings
higher socio-economic position (SEP) is usually associated with
higher consumption of low-fat milk and cheese, lower consump-
tion of full fat milk[7–9]_ENREF_6 and lower morbidity and
mortality from many chronic diseases including CVD and
diabetes[10]. As such the observed associations of cow’s milk
consumption with chronic diseases might be confounded by SEP.
Nevertheless cow’s milk consumption features in many food
guidelines[11], and is becoming increasingly common globally
with economic development[12].
To our knowledge, no randomized controlled trial (RCT) or
Mendelian randomization study has reported the effect of whole
cow’s milk consumption on CVD. Three small short-term RCTs
have reported the effect of whole cow’s milk consumption on some
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CVD risk factors. Among 45 young adults from Spain whole cow’s
milk increased systolic blood pressure (SBP) but had no effect on
diastolic blood pressure (DBP)[13]. Among 32 boys from South
Africa whole cow’s milk increased high density lipoprotein (HDL)-
cholesterol, decreased triglycerides but had no effect on low
density lipoprotein (LDL)-cholesterol[14]. Among 30 young
women from Japan whole cow’s milk increased HDL-cholesterol
but had no effect on triglycerides[15]. A small Mendelian
randomization study found lactase persistence, which enables
people to digest lactose (milk sugar), and may reflect higher cow’s
milk consumption, non-significantly positively associated with
CVD risk factors, such as SBP or DBP, lower HDL-cholesterol,
triglycerides and fasting plasma glucose[16], compared to lactase
non-persistence.
Given the limited experimental evidence concerning whole
cow’s milk consumption, evidence from the majority of the global
population in non-western settings with potentially less or different
confounding may help identify whether the observed associations
of cow’s milk consumption with CVD risk factors are biologically
based or contextually specific results of unmeasured confounding.
Moreover, the range of cow’s milk consumption is also wider in
non-western settings, where it is normal and common to consume
little or no cow’s milk. Clarifying the role of cow’s milk in such
settings now during the ‘window of opportunity’ before cow’s milk
becomes an established part of the diet may also inform key public
health policies. Prospective cohort studies from the developed East
Asian setting of Japan found cow’s milk consumption inversely
associated with CVD[17,18], but not obviously associated with
diabetes[19]. The only study, to date, from China, found whole
cow’s milk consumption negatively associated with type 2
diabetes[20]. Here, we examined the associations of whole cow’s
milk consumption with CVD risk factors in a large study of older
adults (50+ years) from the economically developing non-western
setting of Guangzhou in Southern China, using the Guangzhou
Biobank Cohort Study. We also examined whether these
associations varied by sex or age.
Methods
Ethics statement
The Guangzhou Medical Ethics Committee of the Chinese
Medical Association approved the study and all participants gave
written, informed consent before participation.
Materials
The Guangzhou Biobank Cohort Study (GBCS) is a collabo-
ration between the Guangzhou No. 12 Hospital and the
Universities of Hong Kong and Birmingham and has been
described in detail elsewhere[21]. Participants were recruited from
‘‘The Guangzhou Health and Happiness Association for the
Respectable Elders’’, a community social and welfare association
unofficially aligned with the municipal government where
membership is open to anyone aged 50 years and over for a
nominal monthly fee of 4 Yuan (50 US cents). Participants were
recruited into the study in three recruitment phases: phase 1 took
place from September 2003 to September 2004, phase 2 from
April 2005 to May 2006, and phase 3 from September 2006 to
January 2008, with 10413, 9998 and 10088 recruited participants
respectively. About 7% of permanent Guangzhou residents aged
50 years or older are members of this association, of whom 33%
enrolled for phases1, 2 and 3 recruitment. They were included if
they were capable of consenting, ambulatory, and not receiving
treatment modalities which if omitted might result in immediate
life-threatening risk, such as chemotherapy or radiotherapy for
cancer, or dialysis for renal failure. Participants underwent a half-
day detailed medical interview, including lifestyle and other risk
factors, disease history and physical examination during each
recruitment phase.
In brief, seated blood pressure was recorded as the average of
the last 2 of 3 measurements, using the Omron 705CP
sphygmomanometer (Omron Corp, Kyoto, Japan). Standing
height without shoes was measured to the nearest 0.1 centimeter.
Weight (with participants dressed in light clothing) was measured
to the nearest 0.1 kilogram. We measured hip circumference at the
greatest circumference around the buttocks below the iliac crest
and waist circumference horizontally around the smallest circum-
ference between the ribs and iliac crest, or at the level of the naval
for obese participants. Levels of HDL-cholesterol, LDL-cholester-
ol, triglycerides and plasma glucose were determined using the
Shimadzu CL-8000 Clinical Chemical Analyzer (Shimadzu Corp,
Kyoto, Japan) in the hospital laboratory.
Exposures
Dairy products was obtained from a validated food frequency
questionnaire used in phases 1 and 2, but not phase 3 where a
different dietary instrument was used[21], including whole cow’s
milk, skimmed milk, chocolate milk, dried whole milk, dried
skimmed milk, sweetened condensed milk, ice cream and milk
shake. Participants were asked the portions and frequency of each
dairy product consumed in the past week. Whole cow’s milk was
consumed by 27% of the participants while less than 8% ever
consumed other types of dairy products. Moreover, whole cow’s
milk contains the full nutrition of cow’s milk providing an overall
effect of the nutrition contained in cow’s milk on human health. As
such whole cow’s milk was chosen as the main exposure. Milk
consumption was reported as portions per week and categorized
into never, 1–3 portions (1 portion= 250 ml) per week and .3
portions per week, based on the frequency of consumption and the
usual amount per occasion.
Outcomes
Ten biological outcomes were examined: SBP, DBP, pulse
pressure, HDL-cholesterol, LDL-cholesterol, triglycerides, fasting
plasma glucose, body mass index (BMI), waist-hip ratio (WHR)
and the presence of diabetes (defined as previous diagnosis, fasting
plasma glucose $7.0 mmol/L, or on antidiabetic medication).
These outcomes were chosen to reflect the biological risk factors in
the Framingham equation[22], a risk prediction equation for
ischemic heart disease (IHD), and the Diabetes Prediction Model,
another clinical risk-scoring system[23]. In younger people, SBP
and DBP track together. In older people, however, whereas SBP
continues to rise, DBP falls, and the difference between the two
(pulse pressure) contributes to IHD risk [24].
Covariates
We included age, sex, study-phase, socio-economic position
(SEP), lifestyle, BMI and WHR as potential confounders in the
analysis. SEP was measured at four life stages: childhood SEP
(father’s occupation), early adulthood SEP (education), late SEP
(longest-held education) and current SEP (annual personal income
in yuan). Occupation was categorized as manual (agricultural
work, factory work, or sales and services), non-manual (adminis-
trative/managerial, professional/technical, or military/police) or
others (housewife/husband or retired). Lifestyle included smoking,
alcohol use and physical activity. Smoking was classified as never
smoked, ex-smoker, and current smoker. Alcohol use was classified
as never, less than once per week, 1–4 times per week, 5 or more
times per week, and ex-drinker. Physical activity was categorized
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Table 1. Characteristics by Whole Cow’s Milk Consumption in Older Chinese (5853 men and 14,482 women) in Phases 1 and 2 of
the Guangzhou Biobank Cohort Study, 2003–2006.
Whole cow’s milk consumption (aportions/week)
Men Women
0 1–3 .3 cP value 0 1–3 .3 cP value
N 4360 721 772 10532 1968 1982
Age group (%)
50–54 5.32 12.34 6.61 14.41 25.71 18.62
55–59 18.37 18.86 17.23 27.24 31.20 26.79
60–64 25.46 26.77 24.61 21.61 18.19 20.74
65–69 27.50 25.24 28.11 22.32 16.72 21.19
70–74 19.68 14.56 18.91 11.86 7.37 11.05
75–79 3.19 1.94 3.89 2.23 0.66 1.51
$80 0.48 0.28 0.65 ,0.001 0.32 0.15 0.10 ,0.001
Education (%)
Less than primary school 3.21 1.94 0.91 16.53 7.12 6.87
Primary school 31.01 21.50 16.71 39.74 32.89 30.39
Junior middle school 28.72 30.93 26.55 23.25 29.84 27.26
Senior middle school 21.46 24.27 27.72 15.78 23.34 25.69
Junior college 8.26 10.68 15.16 3.12 4.63 5.86
College or above 7.32 10.68 12.95 ,0.001 1.59 2.19 3.94 ,0.001
Job type (%)
Manual 49.29 43.83 36.27 69.32 59.81 53.48
Non-manual 39.68 35.37 47.80 18.56 17.94 25.48
Other 11.03 20.80 15.93 ,0.001 12.12 22.26 21.04 ,0.001
Father’s occupation (%)
Manual 47.13 48.54 45.60 45.37 46.95 40.21
Non-manual 11.33 13.04 15.03 11.53 12.09 14.63
Other 41.54 38.42 39.38 0.029 43.11 40.96 45.16 ,0.001
bIncome group (%)
,10000 yuan (,US$1250) 23.39 19.97 16.78 47.94 39.45 36.15
10000 to 15000 yuan 45.45 45.30 43.89 41.50 48.47 48.42
$15000 yuan 31.17 34.73 39.33 ,0.001 10.56 12.08 15.43 ,0.001
Smoking status (%)
Never 38.75 44.94 48.19 95.42 97.36 97.28
Ex-smoker 29.94 26.35 31.48 2.08 1.27 1.31
Current smoker 31.31 28.71 20.34 ,0.001 2.50 1.37 1.41 ,0.001
Alcohol use (%)
Never 58.75 64.02 65.55 89.59 89.85 88.88
,1/month 14.57 16.43 14.42 6.14 7.36 6.62
,1/week 4.17 5.24 4.41 1.04 1.16 1.76
1–4/week 8.86 6.94 7.48 1.17 0.63 1.45
.5/week 10.33 7.08 6.81 1.38 0.89 1.09
Ex-drinker 3.31 0.28 1.34 ,0.001 0.68 0.11 0.21 ,0.001
Physical activity (IPAQ) (%)
Inactive 8.35 9.71 7.90 7.82 10.47 7.62
Minimally active 48.35 53.81 50.52 45.20 52.39 49.45
HEPA 43.30 36.48 41.58 0.013 46.98 37.14 42.94 ,0.001
Body mass index 23.54 23.46 23.39 0.46 23.94 23.81 23.54 ,0.001
Waist-hip ratio 0.901 0.899 0.897 0.18 0.859 0.847 0.845 ,0.001
Milk Consumption and Cardiovascular Risk Factors
PLOS ONE | www.plosone.org 3 January 2014 | Volume 9 | Issue 1 | e84813
as inactive, minimally active and HEPA (Health Enhancing
Physical Activity) active. The full range of values of covariates is
shown in Table 1.
Statistical analysis
We did a cross-sectional study of the baseline survey to examine
the associations of exposures with outcomes. The associations of
potential confounders with milk consumption were examined
using chi-square tests for categorical variables and one-way
analysis of variance (ANOVA) for continuous variables. Multivar-
iable censored linear regression was used to assess the adjusted
associations of whole cow’s milk with blood pressure, lipids and
fasting plasma glucose because some people were taking medica-
tions for hypertension (n= 4738), hyperlipidemia (n = 1393) or
diabetes (n = 1662). These models censored the outcome for those
on medication at the observed value so that the true measurement
for blood pressure, LDL-cholesterol, triglycerides and fasting
plasma glucose was assumed to be that observed or higher, while
the true measurement for HDL-cholesterol was assumed to be that
observed or lower. Multivariable linear regression was used to
assess the adjusted associations of whole cow’s milk consumption
with BMI and WHR, and multivariable logistic regression was
used to assess the adjusted association of whole cow’s milk
consumption with diabetes.
Sensitivity analysis
Given whole milk consumption may be modified as part of
lifestyle changes with CVD, we repeated the analysis excluding
people with existing CVD (defined as self-reported CVD, or use of
CVD medication) or diabetes defined as self-reported diabetes, or
use of antidiabetic medication).
We included potential confounders sequentially in the models.
Model 1 adjusted for sex, age (in 5-year age groups) and phase.
Model 2 additionally adjusted for socio-economic position (SEP)
(father’s occupation, education, longest-held occupation and
personal income) and lifestyle (smoking, alcohol use and physical
activity), as categorized in Table 1. The causal role of milk
consumption in adiposity is unclear, so model 3 additionally
adjusted for BMI and WHR. We examined whether CVD risk
factors had different associations with whole milk consumption by
sex or age from the heterogeneity across subgroups and the p-
values of the relevant interaction terms in models including
interactions with other confounders to avoid confounding by these
other interactions.
Information on exposure (whole cow’s milk) and most potential
confounders was missing for less than 5% apart from longest-held
occupation (14.2%) and father’s occupation (42.5%). Initial
analysis showed that using dummy categories for the 2885
participants with missing occupation and for the 8633 participants
with missing father’s occupation produced similar results to
multiple imputations of all missing exposures and potential
confounders[25] from a flexible additive regression model with
predictive mean matching incorporating all exposures, potential
confounders and outcomes with confidence intervals adjusted for
the missing data uncertainty. So, we present results using dummy
categories for the missing occupation and missing father’s
occupation.
Results
Of the original 20,335 participants in phase 1 (10,407) and
phase 2 (9,928) of GBCS, less than 120 had missing information
on any CVD risk factor, so we used all available observations for
each outcome. There were more women (14,482) than men
(5853), and the women were younger (mean age 61.9 (standard
deviation (SD) 6.7) than the men (mean age 64.7 (SD 6.3)). Age
ranged from 50 to 95 years, but only 527 participants were older
than 75 years.
Table 1 shows the associations of whole cow’s milk consumption
with potential confounders. Among all the participants, 14,892
never drank whole cow’s milk, 2689 drank 1–3 portions per week
and 2754 drank .3 portions per week. For men and women,
higher whole cow’s milk consumption was associated with higher
education, non-manual occupation (of self and father) and higher
personal income, but the pattern of associations with age, smoking
status, alcohol use and physical activity was unclear. For women,
but not men, higher whole cow’s milk consumption was associated
lower BMI and WHR.
Table 2 shows the distribution of CVD risk factors and
unadjusted associations of whole cow’s milk consumption with
CVD risk factors. Higher whole milk consumption was associated
with lower SBP, lower DBP, higher HDL-cholesterol, lower LDL-
cholesterol, lower triglycerides, lower BMI and lower WHR, but
had no obvious association with pulse pressure, fasting plasma
glucose, or diabetes.
Table 3 shows the adjusted associations of whole cow’s milk
consumption with CVD risk factors. Whole cow’s milk consump-
tion was associated with lower SBP, lower DBP, lower pulse
pressure, higher HDL-cholesterol, lower triglycerides, lower BMI
and lower WHR, but had no obvious association with LDL-
cholesterol, fasting plasma glucose or diabetes. Adjustment for
confounders (model 2 and model 3 compared with model 1)
somewhat attenuated these associations. Whole milk consumption
was only associated with higher fasting plasma glucose after
adjustment for adiposity. Results using multiple imputation were
similar, as shown in the Table S1 in File S1. Results without
adjusting for medication usage were similar (data not shown).
When people with previous CVD or diabetes were excluded from
the analysis, the results were similar except that the negative
association of whole milk consumption with triglycerides was
somewhat attenuated, and whole milk consumption was no longer
associated with fasting plasma glucose, as shown in Table S2 in
File S1. Results remained similar after adjusting for soy milk
consumption (data not shown).
The associations did not vary with sex (P-values .0.14) or age
(P-values .0.09). However, sex-specific associations are shown in
Table S3 in File S1 and Table S4 in File S1. Associations were
clearer for women than men.
Discussion
In this large study from an under-studied non-western
developing population, whole cow’s milk consumption of more
than 3 portions per week was associated with healthier levels of
most CVD risk factors considered (systolic blood pressure, diastolic
blood pressure, pulse pressure, triglycerides, HDL-cholesterol,
Abbreviations: IPAQ, International Physical Activity Questionnaire; HEPA, health-enhancing physical activity, i.e., vigorous activity at least 3 days a week that corresponds
to a minimum of 1500 metabolic equivalent (MET) minutes per week, or activity 7 days of the week that corresponds to at least 3000 MET minutes per week.
a1 portion = 250 ml; bUS$1= 8 yuan (according to exchange rate from 2003 to 2006).
cP value from chi-square test for categorical variables and from one-way analysis of variants (ANOVA) for continuous variables, 2 sided; bold values indicate P,0.05.
doi:10.1371/journal.pone.0084813.t001
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BMI and WHR) except fasting glucose and had no obvious
associations with LDL-cholesterol or diabetes.
To our knowledge, our study is unique in assessing the
associations of whole cow’s milk consumption with CVD risk
factors in a non-western population whose lifetime experiences are
typical of much of the global population. Other strengths include a
large sample size and detailed recording of milk consumption
frequency and quantity. Nevertheless, limitations exist. First, our
study is cross-sectional, so reverse causation is possible. However,
after excluding participants with previous CVD or diabetes, results
were similar. Second, our participants were not a randomly
selected, representative sample. However, sample selection should
not affect internal associations, unless we missed people with
specific combinations of whole cow’s milk consumption and CVD
risk factors. Furthermore, associations did not differ by age, which
might indicate differential selection into the study. Third, we used
recalled consumption of whole cow’s milk. Any non-differential
misclassification would, most likely, make our results conservative.
Systematic recall bias by CVD risk factors is unlikely as
participants were unaware of this hypothesis at the time of
interview. Fourth, lactase persistence is uncommon in East Asian
populations[26]; some Chinese adults might have difficulty
digesting cow’s milk. However, a study from China suggested
that most healthy adults (81.9%) ingested .250 ml cow’s milk per
portion[27], so our categorization could reflect amounts of cow’s
milk drunk even by those without lactase persistence. Fifth, BMI
and WHR may be mediators rather than confounders of the
association of whole milk consumption with fasting plasma glucose
as the association was only obvious after adjustment for BMI and
WHR. Finally, though we adjusted for life course SEP and lifestyle
in our analysis, residual confounding by SEP is still possible.
Besides, we were unable to adjust for potential confounding by
diet, because of the difficulty of obtaining overall dietary data in
large-scale studies of free-living participants[28]. Hence we do not
know if the associations with whole cow’s milk occurred because
cow’s milk drinkers had a generally healthier diet. However, after
adjusting for soy milk, which is common substitute for cow’s milk
in China, the results remained similar. Furthermore, how a
healthy diet might raise HDL-cholesterol without affecting LDL-
cholesterol is unclear.
Our findings of whole cow’s milk consumption associated with
lower triglycerides and higher HDL-cholesterol, but not with
LDL-cholesterol, are consistent with RCTs[14,15] giving more
credence to our other findings, although whole cow’s milk was not
associated with blood pressure in one small (n = 55) RCT[13]. In
meta-analyses of prospective cohort studies from western popula-
tions high-fat dairy intake was also not clearly associated with
hypertension incidence or blood pressure[29,30]. To our knowl-
edge, no RCT has reported the effect of whole cow’s milk on
fasting plasma glucose or type 2 diabetes. Few observational
studies from China have assessed the association of milk drinking
with CVD risk factors, although one study of middle-aged women
Table 2. Unadjusted Associations of Whole Cow’s Milk Consumption with Cardiovascular Risk Factors in Older Chinese (5853 men
and 14,482 women) in Phases 1 and 2 of the Guangzhou Biobank Cohort Study, 2003–2006.
Mean and standard deviation Whole cow’s milk consumption (bportions/week)
0 1–3 .3
aCVD risk factor Men Women ccoefficient 95% CI coefficient 95% CI
Systolic blood 133.7 130.2 reference 24.73 25.84, 23.62 24.79 25.89, 23.69
pressure (mm Hg) 621.6 622.3
Diastolic blood 76.5 72.9 reference 21.90 22.46, 21.34 22.43 22.99, 21.88
pressure (mm Hg) 611.5 611.1
Pulse pressure 57.2 57.4 reference 22.95 23.72, 22.19 22.43 23.19, 21.67
(mm Hg) 614.7 615.7
HDL-cholesterol 1.53 1.73 reference 0.02 0.01, 0.04 0.03 0.01, 0.05
(mmol/L) 60.39 60.40
LDL-cholesterol 2.99 3.26 reference 0.13 0.10, 0.16 0.10 0.07, 0.13
(mmol/L) 60.64 60.70
Triglycerides 1.58 1.66 reference 20.08 20.13, 20.03 20.09 20.14, 20.04
(mmol/L) 61.21 61.25
Fasting plasma 5.73 5.79 reference 20.20 20.28, 20.13 20.06 20.13, 0.02
glucose (mmol/L) 61.58 61.78
Body mass index 23.5 23.9 reference 20.11 20.25, 0.03 20.32 20.46, 20.19
63.2 63.4
Waist-hip ratio 0.90 0.86 reference 20.01 20.013, 20.007 20.01 20.014, 20.009
60.06 60.06
Prevalence OR 95% CI OR 95% CI
Diabetes 12.31% 13.86% reference 0.87 0.76, 0.98 1.02 0.91, 1.15
aCensored regression was used for systolic blood pressure, diastolic blood pressure, pulse pressure, HDL, LDL, triglyceride and fasting plasma glucose; linear regression
was used for body mass index and waist-hip ratio; logistic regression was used for diabetes.
b1 portion = 250 ml.
cCoefficient means changes in risk factors; bold values indicate P,0.05.
doi:10.1371/journal.pone.0084813.t002
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found an inverse association of whole cow’s milk consumption with
type 2 diabetes[20].
Our study could indicate that whole cow’s milk consumption is
associated with lower risk of CVD but not diabetes, for which
potential mechanisms exist. Cow’s milk protein contains peptides
such as oligopeptides which inhibit angiotensin-converting en-
zyme, thereby specifically reducing blood pressure[31]. Cow’s milk
also contains calcium and vitamin D, which may lower blood
pressure by acting as a negative regulator of the rennin-
angiotensin system and thereby reducing peripheral vascular
resistance[32,33]. However, RCTs have not consistently con-
firmed protective effects of calcium and/or vitamin D supplemen-
tation on blood pressure[34], lipids[35] or CVD[36]. Whole milk
contains fatty acids, such as omega-3s which may reduce
triglycerides, SBP and DBP[37]. However, it is unclear why
whole milk should have heterogeneous associations with CVD risk
factors. Few exposures have been observed to have such a pattern;
although androgens would be expected from RCTs to have such
specific associations with CVD risk factors[38]. Experiments in
mice suggest that omega-3s decrease androgens[39]. However, this
is highly speculative, as it is unclear whether the omega-3s
contained in whole cow’s milk are sufficient to have any such
effect.
From a public health perspective, our study shows that whole
cow’s milk consumption was associated with lower risk of some but
not all CVD risk factors. Given CVD risk factors do not have the
Table 3. Adjusted Associations of Whole Cow’s Milk Consumption with CVD Risk Factors in Older Chinese (5853 men and 14,482
women) in Phases 1 and 2 of the Guangzhou Biobank Cohort Study, 2003–2006.
Whole cow’s milk consumption (cportions/week)
P-value for
trend
N 0 1–3 .3
aCVD risk factor bModel Men Women dcoefficient 95% CI coefficient 95% CI
Systolic blood 1 5826 14431 reference 21.59 22.68, 20.50 23.57 24.64, 22.50 ,0.001
pressure (mm Hg) 2 5445 13422 reference 21.33 22.47, 20.21 23.28 24.39, 22.17 ,0.001
3 5424 13369 reference 21.10 22.20, 20.02 22.56 23.63, 21.49 ,0.001
Diastolic blood 1 5825 14430 reference 20.86 21.43, 20.30 21.83 22.38, 21.28 ,0.001
pressure (mm Hg) 2 5444 13421 reference 20.74 21.33, 20.16 21.70 22.28, 21.13 ,0.001
3 5423 13368 reference 20.62 21.18, 20.06 21.32 21.87, 20.77 ,0.001
Pulse pressure 1 5822 14425 reference 20.72 21.44, 0.01 21.76 22.47, 21.05 ,0.001
(mm Hg) 2 5441 13416 reference 20.65 21.40, 0.10 21.68 22.42, 20.94 ,0.001
3 5420 13363 reference 20.54 21.28, 0.20 21.31 22.04, 20.58 ,0.001
HDL-cholesterol 1 5826 14414 reference 0.03 0.01, 0.05 0.03 0.02, 0.05 ,0.001
(mmol/L) 2 5447 13407 reference 0.03 0.01, 0.05 0.03 0.01, 0.05 ,0.001
3 5414 13334 reference 0.03 0.01, 0.04 0.02 0.01, 0.04 0.002
LDL-cholesterol 1 5812 14370 reference 0.02 20.01, 0.05 0.03 20.003, 0.05 0.042
(mmol/L) 2 5433 13364 reference 0.02 20.01, 0.05 0.02 20.01, 0.05 0.17
3 5400 13291 reference 0.02 20.01, 0.05 0.02 20.01, 0.05 0.08
Triglycerides 1 5827 14419 reference 20.09 20.14, 20.03 20.10 20.15, 20.04 ,0.001
(mmol/L) 2 5448 13411 reference 20.09 20.14, 20.03 20.09 20.15, 20.04 ,0.001
3 5415 13338 reference 20.08 20.13, 20.02 20.06 20.11, 20.002 0.009
Fasting plasma 1 5806 14384 reference 20.02 20.09, 0.06 0.05 20.03, 0.12 0.34
glucose (mmol/L) 2 5424 13379 reference 0.003 20.08, 0.08 0.05 20.03, 0.13 0.24
3 5394 13306 reference 0.01 20.07, 0.09 0.08 0.01, 0.16 0.048
Body mass index 1 5825 14440 reference 20.10 20.24, 0.04 20.31 20.45, 20.17 ,0.001
2 5453 13430 reference 20.07 20.21, 0.08 20.26 20.40, 20.11 ,0.001
Waist-hip ratio 1 5822 14419 reference 20.003 20.01, 20.001 20.01 20.01, 20.006 ,0.001
2 5442 13409 reference 20.002 20.004, 0.001 20.01 20.01, 20.003 ,0.001
OR 95% CI OR 95% CI
Diabetes 1 5818 14418 reference 0.98 0.86, 1.12 1.07 0.95, 1.21 0.35
2 5437 13410 reference 0.98 0.85, 1.12 1.04 0.91, 1.18 0.67
3 5403 13334 reference 0.99 0.86, 1.13 1.09 0.96, 1.24 0.24
aCensored regression was used for systolic blood pressure, diastolic blood pressure, pulse pressure, HDL, LDL, triglyceride and fasting plasma glucose; linear regression
was used for body mass index and waist-hip ratio; logistic regression was used for diabetes.
bModel 1 adjusted for age, sex and phase; Model 2 adjusted for age, sex, phase, SEP (education, father’s occupation, longest-held occupation and personal income) and
lifestyle (smoking status, alcohol use and physical activity); Model 3 adjusted for age, sex, phase, SEP, lifestyle, BMI and WHR.
c1 portion = 250 ml.
dCoefficient means changes in risk factors; bold values indicate P,0.05.
doi:10.1371/journal.pone.0084813.t003
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same effect on absolute risk of CVD or ischemic heart disease in
China as in the west[40], for reasons which have never been
elucidated, policies and recommendation to increase dairy
products consumption to prevent CVD should be made with
caution, especially in places where there is no local evidence of
clear benefits.
Conclusion
This large study from a non-western, developing country
suggests that whole cow’s milk consumption has mixed associa-
tions with CVD risk factors. However, our results are from an
observational study, thus caution should be paid when drawing
conclusions. Further research using suitable study designs, such as
Mendelian randomization or RCTs, should be implemented to
clarify whether the associations of whole cow’s milk with CVD risk
factors are causal or a reflection of bias and confounding.
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